Ledger.Open graph →
SEC Form D · filed February 4, 2021

Jaguar Health, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

James Bochnowski · San Francisco, CADirectorLisa Conte · San Francisco, CAExec · Director · PromoterJonathan Wolin · San Francisco, CAExecGreg J. Divis · San Francisco, CADirectorSteven King · San Francisco, CAExecJohn Micek, Iii · San Francisco, CADirectorJonathan B. Siegel · San Francisco, CADirectorCarol Lizak · San Francisco, CAExecMichael Kramarz · New York, NYExecMichael Englander · New York, NYDirectorMichael Mccormick · New York, NYDirectorGilles J. De Vignemont · Summit, NJExecJulie O'Hara · New York, NYDirectorBlake Dube · Pittsburgh, PAExec · Director · PromoterMorton Wendell · New York, NYDirectorEgen Atkinson · New York, NYExecCraig E. Walters · Ft. Worth., TXExec · Director · PromoterBrian T. Stevens · Farmington Hills, MIExecMichelle D. Spreitzer · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecPeter Henn · Farmington Hills, MIDirectorJoseph Guzel · Palo Alto, CADirectorMclain Southworth · Palo Alto, CADirectorZiqiang Tang · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗